The structural profiles are close, with Novartis carrying a narrow edge on growth. AstraZeneca still has the edge on growth, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.
The comparison is based on similar long-term financial trajectories, not sector labels.
The page question resolves through growth, where AstraZeneca PLC holds the stronger read even though the broader score still favours Novartis AG.
Both operate in: Drug Manufacturers - General
This comparison is based on industry proximity, not on functional trajectory similarity. AZN and NOVN.SW share the same industry classification.
For a similarity-based comparison, see how AstraZeneca and Novartis each position within their functional peer groups in AssetNext.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in growth.
Left means cheaper relative valuation. Higher means stronger structure.
Structure stays fairly close here, while current pricing still looks more supportive for AstraZeneca PLC.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The clearest distance comes from a stronger growth profile.
AstraZeneca PLC still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.
Growth is the clearest driver of the lead, with profitability adding further support — though growth still provides a real counterweight.
Break down the AZN vs NOVN.SW comparison across all dimensions with the full interactive tool.
Explore how AZN and NOVN.SW each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.